205 related articles for article (PubMed ID: 32475748)
1. Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study.
Leiva-Juárez MM; Urso A; Arango Tomás E; Lederer DJ; Sanchez P; Griffith B; Davis RD; Daneshmand M; Hartwig M; Cantu E; Weyant MJ; Bermudez C; D'Cunha J; Machuca T; Wozniak T; Lynch W; Nemeh H; Mulligan M; Song T; Jessen M; Camp PC; Caldeira C; Whitson B; Kreisel D; Ramzy D; D'Ovidio F
J Heart Lung Transplant; 2020 Sep; 39(9):954-961. PubMed ID: 32475748
[TBL] [Abstract][Full Text] [Related]
2. Standard donor lung procurement with normothermic ex vivo lung perfusion: A prospective randomized clinical trial.
Slama A; Schillab L; Barta M; Benedek A; Mitterbauer A; Hoetzenecker K; Taghavi S; Lang G; Matilla J; Ankersmit H; Hager H; Roth G; Klepetko W; Aigner C
J Heart Lung Transplant; 2017 Jul; 36(7):744-753. PubMed ID: 28314503
[TBL] [Abstract][Full Text] [Related]
3. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.
Fisher A; Andreasson A; Chrysos A; Lally J; Mamasoula C; Exley C; Wilkinson J; Qian J; Watson G; Lewington O; Chadwick T; McColl E; Pearce M; Mann K; McMeekin N; Vale L; Tsui S; Yonan N; Simon A; Marczin N; Mascaro J; Dark J
Health Technol Assess; 2016 Nov; 20(85):1-276. PubMed ID: 27897967
[TBL] [Abstract][Full Text] [Related]
4. Extension of donor lung preservation with hypothermic storage after normothermic ex vivo lung perfusion.
Hsin MKY; Iskender I; Nakajima D; Chen M; Kim H; Dos Santos PR; Sakamoto J; Lee J; Hashimoto K; Harmantas C; Hwang D; Waddell T; Liu M; Keshavjee S; Cypel M
J Heart Lung Transplant; 2016 Jan; 35(1):130-136. PubMed ID: 26227444
[TBL] [Abstract][Full Text] [Related]
5. Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study.
Yeung JC; Krueger T; Yasufuku K; de Perrot M; Pierre AF; Waddell TK; Singer LG; Keshavjee S; Cypel M
Lancet Respir Med; 2017 Feb; 5(2):119-124. PubMed ID: 27866861
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Profile of Ex Vivo Lung Perfusate Yields Biomarkers for Lung Transplant Outcomes.
Hsin MK; Zamel R; Cypel M; Wishart D; Han B; Keshavjee S; Liu M
Ann Surg; 2018 Jan; 267(1):196-197. PubMed ID: 29240608
[TBL] [Abstract][Full Text] [Related]
7. Common Criteria for Ex Vivo Lung Perfusion Have No Significant Impact on Posttransplant Outcomes.
Okahara S; Levvey B; McDonald M; D'Costa R; Opdam H; Pilcher DV; Snell GI
Ann Thorac Surg; 2021 Apr; 111(4):1156-1163. PubMed ID: 32890490
[TBL] [Abstract][Full Text] [Related]
8. Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion.
Boffini M; Ricci D; Bonato R; Fanelli V; Attisani M; Ribezzo M; Solidoro P; Del Sorbo L; Ranieri VM; Rinaldi M
Eur J Cardiothorac Surg; 2014 Nov; 46(5):789-93. PubMed ID: 25061216
[TBL] [Abstract][Full Text] [Related]
9. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
[TBL] [Abstract][Full Text] [Related]
10. Transplantation after ex vivo lung perfusion: A midterm follow-up.
Wallinder A; Riise GC; Ricksten SE; Silverborn M; Dellgren G
J Heart Lung Transplant; 2016 Nov; 35(11):1303-1310. PubMed ID: 27381674
[TBL] [Abstract][Full Text] [Related]
11. Assessment of lung edema during ex-vivo lung perfusion by single transpulmonary thermodilution: A preliminary study in humans.
Trebbia G; Sage E; Le Guen M; Roux A; Soummer A; Puyo P; Parquin F; Stern M; Pham T; Sakka SG; Cerf C;
J Heart Lung Transplant; 2019 Jan; 38(1):83-91. PubMed ID: 30391201
[TBL] [Abstract][Full Text] [Related]
12. The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.
Andreasson ASI; Borthwick LA; Gillespie C; Jiwa K; Scott J; Henderson P; Mayes J; Romano R; Roman M; Ali S; Fildes JE; Marczin N; Dark JH; Fisher AJ;
J Heart Lung Transplant; 2017 Sep; 36(9):985-995. PubMed ID: 28551353
[TBL] [Abstract][Full Text] [Related]
13. Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion.
Divithotawela C; Cypel M; Martinu T; Singer LG; Binnie M; Chow CW; Chaparro C; Waddell TK; de Perrot M; Pierre A; Yasufuku K; Yeung JC; Donahoe L; Keshavjee S; Tikkanen JM
JAMA Surg; 2019 Dec; 154(12):1143-1150. PubMed ID: 31596484
[TBL] [Abstract][Full Text] [Related]
14. A CLUE for better assessment of donor lungs: Novel technique in clinical ex vivo lung perfusion.
Ayyat KS; Okamoto T; Niikawa H; Sakanoue I; Dugar S; Latifi SQ; Lebovitz DJ; Moghekar A; McCurry KR
J Heart Lung Transplant; 2020 Nov; 39(11):1220-1227. PubMed ID: 32773324
[TBL] [Abstract][Full Text] [Related]
15. The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion.
Machuca TN; Cypel M; Zhao Y; Grasemann H; Tavasoli F; Yeung JC; Bonato R; Chen M; Zamel R; Chun YM; Guan Z; de Perrot M; Waddell TK; Liu M; Keshavjee S
J Heart Lung Transplant; 2015 Jun; 34(6):849-57. PubMed ID: 25907141
[TBL] [Abstract][Full Text] [Related]
16. Impact of controlled hypothermic preservation on outcomes following heart transplantation.
D'Alessandro D; Schroder J; Meyer DM; Vidic A; Shudo Y; Silvestry S; Leacche M; Sciortino CM; Rodrigo ME; Pham SM; Copeland H; Jacobs JP; Kawabori M; Takeda K; Zuckermann A
J Heart Lung Transplant; 2024 Jul; 43(7):1153-1161. PubMed ID: 38503386
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation.
Valenza F; Rosso L; Coppola S; Froio S; Palleschi A; Tosi D; Mendogni P; Salice V; Ruggeri GM; Fumagalli J; Villa A; Nosotti M; Santambrogio L; Gattinoni L
Transpl Int; 2014 Jun; 27(6):553-61. PubMed ID: 24628890
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function.
Mulloy DP; Stone ML; Crosby IK; Lapar DJ; Sharma AK; Webb DV; Lau CL; Laubach VE; Kron IL
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1208-15. PubMed ID: 22944084
[TBL] [Abstract][Full Text] [Related]
19. Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction.
Hashimoto K; Cypel M; Kim H; Machuca TN; Nakajima D; Chen M; Hsin MK; Zamel R; Azad S; Waddell TK; Liu M; Keshavjee S
Am J Transplant; 2017 May; 17(5):1396-1404. PubMed ID: 27977885
[TBL] [Abstract][Full Text] [Related]
20. The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis.
Luo Q; Zhu L; Wang Y; Wang L; Lv W; Hu J
Ann Transplant; 2019 Dec; 24():647-660. PubMed ID: 31879416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
